BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 19457927)

  • 1. Natural mutations of the anti-Mullerian hormone type II receptor found in persistent Mullerian duct syndrome affect ligand binding, signal transduction and cellular transport.
    Belville C; Maréchal JD; Pennetier S; Carmillo P; Masgrau L; Messika-Zeitoun L; Galey J; Machado G; Treton D; Gonzalès J; Picard JY; Josso N; Cate RL; di Clemente N
    Hum Mol Genet; 2009 Aug; 18(16):3002-13. PubMed ID: 19457927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Müllerian hormone receptor defect.
    di Clemente N; Belville C
    Best Pract Res Clin Endocrinol Metab; 2006 Dec; 20(4):599-610. PubMed ID: 17161334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutive negative regulation in the processing of the anti-Müllerian hormone receptor II.
    Hirschhorn T; di Clemente N; Amsalem AR; Pepinsky RB; Picard JY; Smorodinsky NI; Cate RL; Ehrlich M
    J Cell Sci; 2015 Apr; 128(7):1352-64. PubMed ID: 25663701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of anti-Müllerian hormone (amh) and anti-Müllerian hormone receptor type II (amhrII) in the teleost medaka.
    Klüver N; Pfennig F; Pala I; Storch K; Schlieder M; Froschauer A; Gutzeit HO; Schartl M
    Dev Dyn; 2007 Jan; 236(1):271-81. PubMed ID: 17075875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insensitivity to anti-müllerian hormone due to a mutation in the human anti-müllerian hormone receptor.
    Imbeaud S; Faure E; Lamarre I; Mattéi MG; di Clemente N; Tizard R; Carré-Eusèbe D; Belville C; Tragethon L; Tonkin C; Nelson J; McAuliffe M; Bidart JM; Lababidi A; Josso N; Cate RL; Picard JY
    Nat Genet; 1995 Dec; 11(4):382-8. PubMed ID: 7493017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genetics and molecular pathology of anti-Mullerian hormone and its receptor].
    Picard JY; Belville C
    J Soc Biol; 2002; 196(3):217-21. PubMed ID: 12462075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMH and AMH receptor defects in persistent Müllerian duct syndrome.
    Josso N; Belville C; di Clemente N; Picard JY
    Hum Reprod Update; 2005; 11(4):351-6. PubMed ID: 15878900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of the anti-Müllerian hormone, the anti-Müllerian hormone receptor, and galactose-1-phosphate uridyl transferase genes in patients with the Mayer-Rokitansky-Küster-Hauser syndrome.
    Zenteno JC; Carranza-Lira S; Kofman-Alfaro S
    Arch Gynecol Obstet; 2004 May; 269(4):270-3. PubMed ID: 15221321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent Mullerian duct syndrome caused by both a 27-bp deletion and a novel splice mutation in the MIS type II receptor gene.
    Hoshiya M; Christian BP; Cromie WJ; Kim H; Zhan Y; MacLaughlin DT; Donahoe PK
    Birth Defects Res A Clin Mol Teratol; 2003 Oct; 67(10):868-74. PubMed ID: 14745940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the functional binding sites for TGF-beta on the type II receptor leads to suppression of TGF-beta signaling.
    Shimanuki T; Hara T; Furuya T; Imamura T; Miyazono K
    Oncogene; 2007 May; 26(23):3311-20. PubMed ID: 17146441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperproliferation of mitotically active germ cells due to defective anti-Müllerian hormone signaling mediates sex reversal in medaka.
    Nakamura S; Watakabe I; Nishimura T; Picard JY; Toyoda A; Taniguchi Y; di Clemente N; Tanaka M
    Development; 2012 Jul; 139(13):2283-7. PubMed ID: 22627284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS.
    Masiakos PT; MacLaughlin DT; Maheswaran S; Teixeira J; Fuller AF; Shah PC; Kehas DJ; Kenneally MK; Dombkowski DM; Ha TU; Preffer FI; Donahoe PK
    Clin Cancer Res; 1999 Nov; 5(11):3488-99. PubMed ID: 10589763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The type 2 anti-Müllerian hormone receptor has splice variants that are dominant-negative inhibitors.
    Imhoff FM; Yang D; Mathew SF; Clarkson AN; Kawagishi Y; Tate WP; Koishi K; McLennan IS
    FEBS Lett; 2013 Jun; 587(12):1749-53. PubMed ID: 23624077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autosomal recessive segregation of a truncating mutation of anti-Müllerian type II receptor in a family affected by the persistent Müllerian duct syndrome contrasts with its dominant negative activity in vitro.
    Messika-Zeitoun L; Gouédard L; Belville C; Dutertre M; Lins L; Imbeaud S; Hughes IA; Picard JY; Josso N; di Clemente N
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4390-7. PubMed ID: 11549681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification, expression, and regulation of anti-Müllerian hormone type-II receptor in the embryonic chicken gonad.
    Cutting AD; Ayers K; Davidson N; Oshlack A; Doran T; Sinclair AH; Tizard M; Smith CA
    Biol Reprod; 2014 May; 90(5):106. PubMed ID: 24621923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deregulation of anti-Mullerian hormone/BMP and transforming growth factor-beta pathways in Leydig cell lesions developed in male heterozygous multiple endocrine neoplasia type 1 mutant mice.
    Hussein N; Lu J; Casse H; Fontanière S; Morera AM; Guittot SM; Calender A; Di Clemente N; Zhang CX
    Endocr Relat Cancer; 2008 Mar; 15(1):217-27. PubMed ID: 18310289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assembly of TbetaRI:TbetaRII:TGFbeta ternary complex in vitro with receptor extracellular domains is cooperative and isoform-dependent.
    Zúñiga JE; Groppe JC; Cui Y; Hinck CS; Contreras-Shannon V; Pakhomova ON; Yang J; Tang Y; Mendoza V; López-Casillas F; Sun L; Hinck AP
    J Mol Biol; 2005 Dec; 354(5):1052-68. PubMed ID: 16289576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three novel AMH gene mutations in a patient with persistent mullerian duct syndrome and normal AMH serum dosage.
    Menabò S; Balsamo A; Nicoletti A; Gennari M; Pirazzoli P; Cicognani A; Baldazzi L
    Horm Res; 2008; 70(2):124-8. PubMed ID: 18547961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Anti-Mullerian Hormone and Anti-Mullerian Hormone Type II Receptor Variants in Women with Repeated Implantation Failures.
    Fu YX; Yang HM; OuYang XE; Hu R; Hu T; Wang FM
    Reprod Sci; 2021 Feb; 28(2):406-415. PubMed ID: 32845508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testicular anti-Müllerian hormone: clinical applications in DSD.
    Josso N; Rey R; Picard JY
    Semin Reprod Med; 2012 Oct; 30(5):364-73. PubMed ID: 23044872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.